SUBSTANCE-P-LIKE IMMUNOREACTIVITY, CHOLINE-ACETYLTRANSFERASE ACTIVITY AND CHOLINERGIC MUSCARINIC RECEPTORS IN ALZHEIMERS-DISEASE AND MULTIINFARCT DEMENTIA

被引:44
作者
SAKURADA, T
ALUFUZOFF, I
WINBLAD, B
NORDBERG, A
机构
[1] UNIV UPPSALA, DEPT PHARMACOL, BOX 591, S-75124 UPPSALA, SWEDEN
[2] TOHOKU COLL PHARMACEUT SCI, DEPT PHARMACOL, SENDAI, MIYAGI 983, JAPAN
[3] KAROLINSKA INST, DEPT GERIATR MED, S-10401 STOCKHOLM 60, SWEDEN
[4] KAROLINSKA INST, DEPT PATHOL, S-10401 STOCKHOLM 60, SWEDEN
关键词
Alzheimer's disease; Brain; Choline acetyltransferase; Multi-infarct dementia; Muscarinic receptor; Substance P;
D O I
10.1016/0006-8993(90)91561-T
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Substance P-like immunoreactivity, choline acetyltransferase (ChAT) activity and muscarinic cholinergic receptors were measured in brains from 9 indinviduals with senile dementia of the Alzheimer type (AD), 4 individuals with multi-infarct dementia (MID), 6 individuals with mixed type of dementia (AD/MID) and 9 controls. The ChAT activity was markedly reduced (50-60%) in the hippocampus of all demented brains. The number of muscarinic cholinergic receptors was reduced only in the MID and AD/MID brains. No significant difference in substance P-like immunoreactivity was measured in 4 regions of AD brains in comparison to controls. In the combined MID plus AD/MID groups a significant reduction in substance P-like immunoreactivity (-35%) was measured in the hippocampus while no change was found in the frontal cortex, amygdala and caudate nucleus. The findings support the assumption of differences in selectivity of damage between AD and AD/MID, MID. © 1990.
引用
收藏
页码:329 / 332
页数:4
相关论文
共 21 条
[1]   HISTOPATHOLOGICAL CRITERIA FOR PROGRESSIVE DEMENTIA DISORDERS - CLINICAL-PATHOLOGICAL CORRELATION AND CLASSIFICATION BY MULTIVARIATE DATA-ANALYSIS [J].
ALAFUZOFF, I ;
IQBAL, K ;
FRIDEN, H ;
ADOLFSSON, R ;
WINBLAD, B .
ACTA NEUROPATHOLOGICA, 1987, 74 (03) :209-225
[2]   TOPOGRAPHICAL LOCALIZATION OF CHOLINE-ACETYLTRANSFERASE WITHIN THE HUMAN SPINAL-CORD AND A COMPARISON WITH SOME OTHER SPECIES [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
GILLBERG, PG .
BRAIN RESEARCH, 1981, 211 (02) :329-340
[3]   SUBSTANCE-P-LIKE IMMUNOREACTIVITY IS REDUCED IN ALZHEIMERS-DISEASE CEREBRAL-CORTEX [J].
BEAL, MF ;
MAZUREK, MF .
NEUROLOGY, 1987, 37 (07) :1205-1209
[4]   AN ION-EXCHANGE CHROMATOGRAPHY AND RADIOIMMUNOASSAY PROCEDURE FOR MEASURING OPIOID-PEPTIDES AND SUBSTANCE-P [J].
BERGSTROM, L ;
CHRISTENSSON, I ;
FOLKESSON, R ;
STENSTROM, B ;
TERENIUS, L .
LIFE SCIENCES, 1983, 33 (16) :1613-1619
[5]   POST-MORTEM ANALYSES OF NEUROPEPTIDES IN BRAINS FROM SUDDEN INFANT DEATH VICTIMS [J].
BERGSTROM, L ;
LAGERCRANTZ, H ;
TERENIUS, L .
BRAIN RESEARCH, 1984, 323 (02) :279-285
[6]   CORTICAL SUBSTANCE P-LIKE IMMUNOREACTIVITY IN CASES OF ALZHEIMERS-DISEASE AND SENILE DEMENTIA OF THE ALZHEIMER TYPE [J].
CRYSTAL, HA ;
DAVIES, P .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (06) :1781-1784
[7]   REDUCED SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN CEREBRAL-CORTEX FROM CASES OF ALZHEIMER-DISEASE AND ALZHEIMER SENILE DEMENTIA [J].
DAVIES, P ;
KATZMAN, R ;
TERRY, RD .
NATURE, 1980, 288 (5788) :279-280
[8]   RAPID RADIOCHEMICAL METHOD FOR DETERMINATION OF CHOLINE-ACETYLTRANSFERASE [J].
FONNUM, F .
JOURNAL OF NEUROCHEMISTRY, 1975, 24 (02) :407-409
[9]   TRANSMITTER DEFICITS IN ALZHEIMERS-DISEASE [J].
HARDY, J ;
ADOLFSSON, R ;
ALAFUZOFF, I ;
BUCHT, G ;
MARCUSSON, J ;
NYBERG, P ;
PERDAHL, E ;
WESTER, P ;
WINBLAD, B .
NEUROCHEMISTRY INTERNATIONAL, 1985, 7 (04) :545-563
[10]   CHOLINERGIC RECEPTORS IN HUMAN HIPPOCAMPUS - REGIONAL DISTRIBUTION AND VARIANCE WITH AGE [J].
NORDBERG, A ;
WINBLAD, B .
LIFE SCIENCES, 1981, 29 (19) :1937-1944